Fertility of Spinal Cord Injured Men (FertiSCI)

April 16, 2021 updated by: Assistance Publique - Hôpitaux de Paris

Evolution of Sperm Parameters and Study of Risk Factors of Impairment of Sperm Quality in Spinal Cord Injuries. Longitudinal Prospective Study.

Spinal cord injured (SCI) men, para or tetraplegic, most often have an infertility, caused among others by a deficiency of sperm quality particularly motility and vitality. Several mechanisms have been proposed: low frequency of ejaculation, recurrent urinary tract and seminal infections, presence of an inflammatory syndrome (IS) and an oxidative stress (OS). However, no French study of sperm quality has been conducted in this population that could identify aggravating factors of sperm quality and a way to prevent them.

Hypothesis: Sperm parameters decrease rapidly following spinal cord injury and next stabilise. However, unidentified yet risk factors could influence long-term evolution of sperm parameters.

The objective is to study the evolution of sperm parameters during 18 months taking into account bladder management, recurrent urinary tract and bladder infections, IS and OS. The evaluation of these parameters and their consequences will be indicative to determine one or more risk factors of sperm degradation and determine a strategy for long term support to avoid the use of ART either by sperm cryopreservation and/or by preventing risk factors

Study Overview

Detailed Description

SCI men are mostly young adults who have not completed their parental project. Infertility has many causes: erectile dysfunction, anejaculation (85% of SCI ) and altered sperm parameters. Penile vibratory stimulation allows 75 % of the sperm collection. If sperm quality is sufficient, intravaginal insemination of their partner at home is possible. The use of AMP remains common, which is damaging to men non sterile priori. In SCI, sperm concentration remains satisfactory but mobility and vitality are impaired. The installation of this irreversible degradation likely occurs very quickly after the trauma. The possible deterioration of sperm parameters with time is not known. The following pathophysiological mechanisms have been proposed: i) increased scrotal temperature, ii) decreased ejaculatory frequency, iii) recurrent urinary tract and seminal infections, iv ) inflammation and oxidative stress in the semen. Patients, and even rehabilitation doctors often submit an application for preventive sperm conservation but in the absence of prospective longitudinal data on the evolution of sperm quality of SCI men over the time and identified risk factors of degradation, the indication and timing of preventive cryopreservation remain to be defined.

Hypothesis: The sperm parameters, mobility and vitality, in SCI patients with or without penile vibratory stimulation (PVS), decrease in the immediate aftermath of trauma and next stabilize out the occurrence of intercurrent medical events or symptomatic urogenital infections. However, unidentified yet risk factors could influence long-term evolution of these sperm parameters.

Main objective: Monitoring the evolution of sperm parameters for 18 months: concentration, mobility, vitality, sperm morphology, inflammatory syndrome and oxidative stress on 4 ejaculates collected by masturbation or SVP at 6-month intervals.

Secondary objectives: In case of impaired sperm quality, identify risk factors for this change.

SCI men will have 4 medical visits associated to sperm retrieval spaced to 6 months during 18 months. At each visit medical and reproductive informations will be collected.

Knowledge of the evolution of sperm parameters and risk factors of its degradation over time must answer with the criteria of "evidence based medicine" the request of sperm cryopreservation frequently expressed by SCI patients. This study should lead to the optimization of the management of infertility in patients with spinal cord injuries and giving directions for research aiming to prevent the degradation of sperm parameters. Finally, this study should provide the rationale for future research on clinical risk factors and / or biological degradation of sperm and biological markers of risk of degradation.

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75014
        • Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Department of Biology of Reproduction

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 58 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Spinal cord injured men aged between 18 and 60 years
  • Strict antegrade ejaculation obtained by masturbation or penil vibratory stimulation
  • Signature of an informed and written consent to participate to the study.

Exclusion Criteria:

  • Total or partial retrograde ejaculation
  • Major patients protected
  • Men no affiliated with a french social security regime.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Spinal cord injured (SCI) men, para or tetraplegic
SCI men will have 4 medical visits associated to sperm retrieval (penile vibratory stimulation (PVS) or masturbation)
penile vibratory stimulation (PVS) or masturbation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sperm viability: percent of live spermatozoa among 100 counted spermatozoa.
Time Frame: 18 month

Sperm viability is a stable criteria of evaluation and it has a good repeatability in our lab.

Sperm viability is measured on fresh sperm 30 minutes after ejaculation using eosine nigrosine coloration. This measure is repeated on each of the four ejaculates obtained at 6 months apart.

18 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
spermogram
Time Frame: 18 months
Sperm concentration, mobility and morphology
18 months
elastase
Time Frame: 6 month
Measure of inflammation
6 month
DNA fragmentation
Time Frame: 18 months
Sperm DNA integrity, measures oxidative stress
18 months
8 Hydroxydesoxyguanosine (8OHdG)
Time Frame: 18 months
Oxydative stress
18 months
Seminal biochemistry
Time Frame: 18 months
Secretion of seminal tract
18 months
Urinary and seminal infections
Time Frame: 18 months
Bacteriological analysis of sperm and urine
18 months
Mode of urinary catheter
Time Frame: 18 months
18 months
Spinal cord injury type
Time Frame: 0 months
Type and level of the lesion
0 months
Concomitant treatments
Time Frame: 18 months
18 months
Patient age and time to spinal cord injury
Time Frame: 18 months
18 months
Sperm viability: percent of live spermatozoa among 100 counted spermatozoa.
Time Frame: 6 months

Sperm viability is a stable criteria of evaluation and it has a good repeatability in our lab.

Sperm viability is measured on fresh sperm 30 minutes after ejaculation using eosine nigrosine coloration. This measure is repeated on each of the four ejaculates obtained at 6 months apart.

6 months
Sperm viability: percent of live spermatozoa among 100 counted spermatozoa.
Time Frame: 12 months

Sperm viability is a stable criteria of evaluation and it has a good repeatability in our lab.

Sperm viability is measured on fresh sperm 30 minutes after ejaculation using eosine nigrosine coloration. This measure is repeated on each of the four ejaculates obtained at 6 months apart.

12 months
Sperm viability: percent of live spermatozoa among 100 counted spermatozoa.
Time Frame: 0 months

Sperm viability is a stable criteria of evaluation and it has a good repeatability in our lab.

Sperm viability is measured on fresh sperm 30 minutes after ejaculation using eosine nigrosine coloration. This measure is repeated on each of the four ejaculates obtained at 6 months apart.

0 months
elastase
Time Frame: 0 month
Measure of inflammation
0 month
elastase
Time Frame: 12 month
Measure of inflammation
12 month
elastase
Time Frame: 18 month
Measure of inflammation
18 month
spermogram
Time Frame: 0 months
Sperm concentration, mobility and morphology
0 months
spermogram
Time Frame: 6 months
Sperm concentration, mobility and morphology
6 months
spermogram
Time Frame: 12 months
Sperm concentration, mobility and morphology
12 months
DNA fragmentation
Time Frame: 0 month
Sperm DNA integrity, measures oxidative stress
0 month
DNA fragmentation
Time Frame: 6 months
Sperm DNA integrity, measures oxidative stress
6 months
DNA fragmentation
Time Frame: 12 months
Sperm DNA integrity, measures oxidative stress
12 months
8 Hydroxydesoxyguanosine (8OHdG)
Time Frame: 0 months
Oxydative stress
0 months
8 Hydroxydesoxyguanosine (8OHdG)
Time Frame: 6 months
Oxydative stress
6 months
Seminal biochemistry
Time Frame: 0 months
Secretion of seminal tract
0 months
Seminal biochemistry
Time Frame: 6 months
Secretion of seminal tract
6 months
Seminal biochemistry
Time Frame: 12 months
Secretion of seminal tract
12 months
Urinary and seminal infections
Time Frame: 0 months
Bacteriological analysis of sperm and urine
0 months
Urinary and seminal infections
Time Frame: 6 months
Bacteriological analysis of sperm and urine
6 months
Urinary and seminal infections
Time Frame: 12 months
Bacteriological analysis of sperm and urine
12 months
Mode of urinary catheter
Time Frame: 0 months
0 months
Mode of urinary catheter
Time Frame: 6 months
6 months
Mode of urinary catheter
Time Frame: 12 months
12 months
Concomitant treatments
Time Frame: 0 month
0 month
Concomitant treatments
Time Frame: 6 months
6 months
Concomitant treatments
Time Frame: 12 months
12 months
Patient age and time to spinal cord injury
Time Frame: 0 month
0 month
Patient age and time to spinal cord injury
Time Frame: 6 months
6 months
Patient age and time to spinal cord injury
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Céline Chalas, PhD, Cochin Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 24, 2014

Primary Completion (Actual)

April 5, 2018

Study Completion (Actual)

April 5, 2018

Study Registration Dates

First Submitted

May 19, 2014

First Submitted That Met QC Criteria

May 21, 2014

First Posted (Estimate)

May 22, 2014

Study Record Updates

Last Update Posted (Actual)

April 19, 2021

Last Update Submitted That Met QC Criteria

April 16, 2021

Last Verified

April 1, 2021

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sperm Parameters of Spinal Cord Injured Men

Clinical Trials on penile vibratory stimulation (PVS) or masturbation

3
Subscribe